Biomarkers of Alzheimer's include abnormal levels of betaamyloid and tau in blood and cerebrospinal fluid (CSF, the fluid surrounding the brain), the accumulation of betaamyloid and abnormal tau as seen on positron emission tomography (PET), decreased glucose metabolism as seen using PET and a compound called [ 18 F]fluorodeoxyglucose, brain atrophy as determined by structural magnetic resonance imaging (sMRI), and increased levels of the neurofilament light chain protein in CSF or blood, among others
PlexusDx patients receive detailed storage guidance with every prescription, because maintaining medication integrity directly affects treatment outcomes and your investment in personalized GLP-1 therapy
In numerous places, it is categorized as a research chemical and is not approved for human use by regulatory agencies, such as the FDA in the USA, the MHRA in the UK, and the TGA in Australia
On average, approximately 30,000 static panelists meet this criterion each quarter